How GlaxoSmithKline Shareholders Will Benefit From Today's Low Prices

The Motley Fool
Updated
Photo: Ian Wilson. Cropped & adjusted. Licence: https://creativecommons.org/licenses/by/2.0/
Photo: Ian Wilson. Cropped & adjusted. Licence: https://creativecommons.org/licenses/by/2.0/

If you're an active buyer or re-investor in a high-yielding share like GlaxoSmithKline(LSE: GSK), you should be cheering lower prices. Over time, compounding its dividend will be much more effective when prices stay low.

///>

Our top analysts have highlighted five shares in the FTSE 100 in our special free report "5 Shares To Retire On". To find out the names of the shares and the reasons behind their inclusion, simply click here to view it immediately with no obligations whatsoever.

Owain Bennallack has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

Advertisement